© Wiley Periodicals, Inc.
Edited By: Henrique von Gersdorff
Impact Factor: 2.026
ISI Journal Citation Reports © Ranking: 2015: 176/256 (Neurosciences)
Online ISSN: 1098-2396
Recently Published Issues
The articles below have been specially selected by our editors to highlight to the Synapse community. Read more
Activation of β-adrenergic receptors in rat visual cortex expands astrocytic processes and reduces extracellular space volume
Ang Doma Sherpa, Fanrong Xiao, Neethu Joseph, Chiye Aoki and Sabina Hrabetova
Permeability of blood–brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease
Thibaud Thiollier, Caisheng Wu, Hugues Contamin, Qin Li, Jinlan Zhang and Erwan Bezard
Cerebrolysin improves memory and ameliorates neuronal atrophy in spontaneously hypertensive, aged rats
Carlos Solis-Gaspar, Ruben A. Vazquez-Roque, Ma De Jesús Gómez-Villalobos and Gonzalo Flores
Synaptic number changes in the medial prefrontal cortex across adolescence in male and female rats: A role for pubertal onset
Carly M. Drzewiecki, Jari Willing and Janice M. Juraska
News & Special Features
Synapse is pleased to welcome Erwan Bezard and Benjamin Hall as new Associate Editors
Benjamin Hall is a Principal Scientist at F. Hoffman-La Roche Ltd., working at the Roche Innovation Center Basel, Switzerland. He also holds an Adjunct Professorship in the Cell and Molecular Biology Department and Neuroscience Program at Tulane University in New Orleans, Louisiana. His research investigates the role of NMDA receptors and late-stage transcription factors in the regulation of synaptic function in the cortex with a focus on synapse development and cortical circuit formation in relation to neurodevelopmental disorders. Recent work from his lab is also focused on understanding the cellular mechanisms that initiate the antidepressant actions of low-dose ketamine. He is a National Science Foundation CAREER award recipient, a two-time recipient of the Brain and Behavior Foundation’s NARSAD Young Investigator award, a Grass Foundation Fellow, and previous Staglin Music Festival Investigator.
Erwan Bezard is the Director of the Institute of Neurodegenerative Diseases at University of Bordeaux, which features preclinical and clinical researchers working towards development of therapeutic solutions. He has authored or co-authored over 198 professional publications, most of which are on Parkinson's disease and related disorders. Listed in the Top 1% of the most cited neuroscientists, he is known for his work (i) on the compensatory mechanisms that mask the progression of Parkinson's disease, (ii) on the pathophysiology of levodopa-induced dyskinesia and (iii) on the mechanisms of neurodegeneration in synucleopathies. His current research interests include the study of the levodopa-induced dyskinesia, the intimate mechanisms of cell death in Parkinson’s disease, the modelling of disease progression and the development of new strategies to alleviate symptoms and/or to slow disease progression.